|
|
||||||||||
|
J Am Coll Cardiol, 2004; 43:8-14, doi:10.1016/j.jacc.2003.06.019 © 2004 by the American College of Cardiology Foundation |







* Division of Cardiology and Biostatistics, Mid America Heart Institute, St. Luke's Hospital, Kansas City, Missouri, USA
Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan, USA
Manuscript received April 18, 2003; revised manuscript received June 23, 2003, accepted June 30, 2003.
* Reprint requests and correspondence: Dr. Roberto A. Corpus, Assistant Professor, Department of Cardiology, University of Missouri-Kansas City, Mid America Heart Institute, 4401 Wornall Road, Kansas City, Missouri 64111, USA.
rjcorpus{at}yahoo.com
OBJECTIVES: We examined the association between glycemic control determined by preprocedural hemoglobin A1c (A1c) and the incidence of target vessel revascularization (TVR) in diabetic patients undergoing elective percutaneous coronary intervention (PCI).
BACKGROUND: Patients with diabetes mellitus (DM) have increased rates of restenosis and a worse clinical outcome after PCI than patients without DM.
METHODS: A total of 239 patients (60 without DM and 179 with DM) were enrolled in this study. Optimal glycemic control was defined as A1c
7%, and suboptimal control was defined as A1c >7%. Follow-up was performed at six and 12 months after the index intervention.
RESULTS: Diabetic patients with optimal glycemic control had a rate of 12-month TVR similar to that of nondiabetic patients (15% vs. 18%, p = NS). Diabetic patients with A1c >7% had a significantly higher rate of TVR than those with A1c <7% (34% vs. 15%, p = 0.02). In a multiple logistic regression analysis, A1c >7% was a significant independent predictor of TVR (odds ratio 2.87, 95% confidence interval 1.13 to 7.24; p = 0.03). Optimal glycemic control was associated with a lower rate of cardiac rehospitalization (15% vs. 31%, p = 0.03) and recurrent angina (13% vs. 37%, p = 0.002) at 12-month follow-up.
CONCLUSIONS: In diabetic patients undergoing elective PCI, optimal glycemic control (A1c
7%) is associated with a lower rate of TVR, cardiac rehospitalization, and recurrent angina. These data suggest that aggressive treatment of DM to achieve A1c
7% is beneficial in improving the clinical outcome after PCI.
| ||||||||||||||||||||
This article has been cited by other articles:
![]() |
R Peter, A Cox, and M Evans Management of diabetes in cardiovascular patients Heart, March 1, 2008; 94(3): 369 - 375. [Full Text] [PDF] |
||||
![]() |
M. L. Brown, T. M. Sundt III, and B. J. Gersh Indications for Revascularization Card. Surg. Adult, January 1, 2008; 3(2008): 551 - 572. [Full Text] |
||||
![]() |
C. Berry, J.-C. Tardif, and M. G. Bourassa Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization J. Am. Coll. Cardiol., February 13, 2007; 49(6): 643 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hofmann, A. Niessner, A. Kypta, C. Steinwender, J. Kammler, K. Kerschner, M. Grund, F. Leisch, and K. Huber Risk Score for Peri-Interventional Complications of Carotid Artery Stenting Stroke, October 1, 2006; 37(10): 2557 - 2561. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J Hong, M H Kim, T H Ahn, Y K Ahn, J H Bae, W J Shim, Y M Ro, and D-S Lim Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes Heart, August 1, 2006; 92(8): 1119 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Stettler, S Allemann, M Egger, S Windecker, B Meier, and P Diem Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials Heart, May 1, 2006; 92(5): 650 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srivastava, K. V. Ramana, R. Tammali, S. K. Srivastava, and A. Bhatnagar Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes, April 1, 2006; 55(4): 901 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seabra-Gomes Percutaneous coronary interventions with drug eluting stents for diabetic patients. Heart, March 1, 2006; 92(3): 410 - 419. [Full Text] [PDF] |
||||
![]() |
W. W. O'Neill, S. R. Dixon, and C. L. Grines The year in interventional cardiology J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1117 - 1134. [Full Text] [PDF] |
||||
![]() |
J. D. Flaherty and C. J. Davidson Diabetes and Coronary Revascularization JAMA, March 23, 2005; 293(12): 1501 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Finn, I. F. Palacios, A. Kastrati, and H. K. Gold Drug-eluting stents for diabetes mellitus: A rush to judgment? J. Am. Coll. Cardiol., February 15, 2005; 45(4): 479 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al. Highlights of the year in JACC 2004 J. Am. Coll. Cardiol., January 4, 2005; 45(1): 137 - 153. [Full Text] [PDF] |
||||
![]() |
C Briguori, G Condorelli, F Airoldi, G W Mikhail, B Ricciardelli, and A Colombo Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients Heart, December 1, 2004; 90(12): 1481 - 1482. [Full Text] [PDF] |
||||
![]() |
Hyperglycemia Linked with TVR After PCI Journal Watch Cardiology, March 26, 2004; 2004(326): 1 - 1. [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |